Learn more
Log in
0 followers
Ashvattha Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel hydroxyl dendrimer (HD) therapeutics (HDTs) to treat unmet medical needs in oncology, ophthalmology, and inflammatory diseases.
Industries
Headquarters
Stage
Employees
Links
Jeffrey L. Cleland
7 members
6 members
2 members
MapLight Therapeutics
1 follower
Immunome
Thermo Fisher Scientific
129 followers
Vertex Pharmaceuticals
44 followers
Myriad Genetics
33 followers
Discover companies